![Overall and relapse-free survival rates in AML patients with no DMRGM,... | Download Scientific Diagram Overall and relapse-free survival rates in AML patients with no DMRGM,... | Download Scientific Diagram](https://www.researchgate.net/publication/303716743/figure/fig1/AS:484373641338881@1492495083612/Overall-and-relapse-free-survival-rates-in-AML-patients-with-no-DMRGM-one-DMRGM-and-two.png)
Overall and relapse-free survival rates in AML patients with no DMRGM,... | Download Scientific Diagram
![Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes | Blood Cancer Journal Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-021-00516-1/MediaObjects/41408_2021_516_Fig1_HTML.png)
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes | Blood Cancer Journal
![Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute](https://www.recoveryanswers.org/assets/Total-expenditure-cost-of-addiction-medications-length-of-treatment-Buprenorphine-Methadone-Treatment-Among-Medicaid-Members-Reducing-Relapse-Health-Care-Costs-Medicaid-Behavioral-health-Clark-Graph-1024x448.jpg)
Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute
![Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni, Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni,](https://journals.sagepub.com/cms/10.1177/13524585211010294/asset/images/large/10.1177_13524585211010294-fig3.jpeg)
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies - Nicola De Stefano, Maria Pia Sormani, Gavin Giovannoni,
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study | PLOS ONE
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk | Haematologica
Overall and relapse-free survival rates in AML cases with and without... | Download Scientific Diagram
![Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011 Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011](https://journals.sagepub.com/cms/10.1177/1352458511406309/asset/images/large/10.1177_1352458511406309-fig2.jpeg)
Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011
![Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/1b1e5ec1-3d15-4344-9277-dd1d26e06c7e/mfig002.jpg)